219.98
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $219.98, with a volume of 4.54M.
It is up +0.10% in the last 24 hours and down -7.71% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$219.75
Open:
$218.15
24h Volume:
4.54M
Relative Volume:
1.24
Market Cap:
$155.50B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
43.58
EPS:
5.0475
Net Cash Flow:
$5.25B
1W Performance:
+0.20%
1M Performance:
-7.71%
6M Performance:
+10.12%
1Y Performance:
+9.11%
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DHR
Danaher Corp
|
219.98 | 155.34B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
TMO
Thermo Fisher Scientific Inc
|
527.17 | 202.81B | 44.56B | 6.73B | 6.29B | 17.74 |
|
IDXX
Idexx Laboratories Inc
|
648.73 | 51.63B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
128.90 | 36.49B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
329.20 | 32.08B | 3.11B | 648.81M | 602.27M | 10.88 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
This Diagnostic Company Is Rapidly Expanding in Emerging Markets: What to Know - MedCity News
Laser Capture Microdissection Market Is Going to Boom | Leica - openPR.com
Rhumbline Advisers Boosts Holdings in Danaher Corporation $DHR - MarketBeat
Madison Asset Management LLC Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Do Wall Street Analysts Like Danaher Stock? - Barchart.com
ING Groep NV Buys 206,976 Shares of Danaher Corporation $DHR - MarketBeat
Impax Asset Management Group plc Reduces Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by First National Trust Co - MarketBeat
Danaher Corporation (DHR) Announces Board Member Retirement - GuruFocus
Danaher announces retirement of board member Jessica L. Mega - Investing.com
Molecular Devices and Automata partner to connect lab instruments end-to-end - R&D World
Peering Into Danaher Corp's Recent Short Interest - Benzinga
Applied Finance Capital Management LLC Reduces Stock Position in Danaher Corporation $DHR - MarketBeat
Johnson Investment Counsel Inc. Grows Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Trimmed by Foresight Group Ltd Liability Partnership - MarketBeat
SCIEX announces Echo® MS+ system integration with ZenoTOF 8600 system, delivering enhanced sensitivity for high-throughput screening - BioSpace
Calculating The Fair Value Of Danaher Corporation (NYSE:DHR) - Yahoo Finance
DHR SEC FilingsDanaher Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Promising Biotech Stocks To Watch NowFebruary 7th - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Sells 8,334 Shares of Danaher Corporation $DHR - MarketBeat
Biotech Stocks To Add to Your WatchlistFebruary 6th - MarketBeat
M.D. Sass LLC Has $72.44 Million Position in Danaher Corporation $DHR - MarketBeat
Envestnet Asset Management Inc. Buys 23,690 Shares of Danaher Corporation $DHR - MarketBeat
The Evolution of a Compounder: A Deep-Dive Into Fortive Corp (FTV) - FinancialContent
Bessemer Group Inc. Raises Position in Danaher Corporation $DHR - MarketBeat
ABN AMRO Bank N.V. Makes New $7.27 Million Investment in Danaher Corporation $DHR - MarketBeat
Border to Coast Pensions Partnership Ltd Raises Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR): A Bull Case Theory - Finviz
Danaher Corporation $DHR Shares Purchased by Machina Capital S.A.S. - MarketBeat
Jones Financial Companies Lllp Has $26.94 Million Holdings in Danaher Corporation $DHR - MarketBeat
The Top 5 Analyst Questions From Danaher's Q4 Earnings Call - Finviz
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Earnings call transcript: Danaher Q4 2025 earnings beat forecasts, stock dips - Investing.com
Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade - TechStock²
Downstream Processing Market By Top Trending Companies- GE - openPR.com
Danaher Corporation $DHR Shares Purchased by AlphaQuest LLC - MarketBeat
Mawer Investment Management Ltd. Lowers Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Danaher Corporation $DHR Shares Acquired by Principal Financial Group Inc. - MarketBeat
UMB Bank n.a. Sells 4,940 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Danaher Corporation $DHR Shares Purchased by Private Wealth Partners LLC - MarketBeat
Bryn Mawr Trust Advisors LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Federated Hermes Inc. Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Welch & Forbes LLC Sells 72,790 Shares of Danaher Corporation $DHR - MarketBeat
National Pension Service Has $286.76 Million Holdings in Danaher Corporation $DHR - MarketBeat
Keybank National Association OH Trims Stake in Danaher Corporation $DHR - MarketBeat
Pittenger & Anderson Inc. Lowers Position in Danaher Corporation $DHR - MarketBeat
Nan Fung Trinity HK Ltd. Invests $11.72 Million in Danaher Corporation $DHR - MarketBeat
Danaher Invests In Automata To Deepen AI Driven Lab Workflows - Yahoo Finance UK
UBS Reaffirms Their Buy Rating on Danaher (DHR) - The Globe and Mail
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):